New York Eye and Ear Infirmary of Mount Sinai (NYEE) 2022 Specialty Report NYEE remains more committed than ever to our 200-year mission of world-class patient care, scientific discovery to find novel treatments for ocular diseases, and unparalleled education of future ophthalmic leaders. We are pleased to share with you the Department of Ophthalmology 2022 Specialty Report, which showcases the tremendous work happening at our institution, as we continue to envision our third century of community care, vision research, and education. The 2022 Issue of the report includes the following articles:
FEATURED ARTICLES
A Resident Draws on a Diverse Team to Address a Traumatic Eye Injury
The case of a 56-year-old man with a 10mm shard of metal penetrating his left eye shows the importance of triage in ensuring the best outcomes.
Surgeons at NYEE and Mount Sinai Team Up for a Five-Year-Old Patient
Technology and surgical skills come together as surgeons’ team up to repair an arteriovenous malformation in the orbit compressing the optic nerve.
New and Advanced Ambulatory Surgery Center Will Become Leading Edge of Transformation
The planned state-of-the-art ASC reflects a partnership between NYEE, Mount Sinai Ambulatory Ventures, our community physicians, and Merritt Healthcare.
A New Industry Partner Is a Milestone for Ophthalmic Robotics
The recent acquisition of Preceyes by industry leader ZEISS Medical, will further advance the field of microsurgical robotics.
Two Distinct Pathways Are Identified for Age-Related Macular Degeneration
Researches have shed a new light into understanding the links between advanced age-related macular degeneration, cardiovascular disease, and stroke.
Researchers Target a Major Hurdle for Retinal Stem Cell Replacement
Researchers have discovered a potential way around the production of epiretinal membranes, a major adverse event in the use of induced pluripotent stem cells, to treat AMD.
New Imaging Shows First-Time Evidence of Vaso-Occlusion Dynamics in Sickle Cell Disease
Mount Sinai researchers reveal cellular phenomena of sickle cell capillary blood flow in extraordinary detail, opening the door to earlier diagnosis and individualized treatment.
OTHER ARTICLES IN THE REPORT
• Message From the Department of Ophthalmology Leadership
• NYEE Residents Sharpen Their Skills on Four Complex Cases
• Putting Quality, Safety, and Experience on a Pedestal
• Eye Plaque Radiation Therapy Preserves the Sight of Patients With Invasive Carcinoma
• Helping Low-Vision Patients Lead Independent Lives
• Unraveling the Wound-Healing Magic of the Corneal Epithelium
• A New Study Finds Blacks Have More Advanced Visual Field Loss at First Diagnosis of Glaucoma
• Uncovering Glaucoma’s Vascular Link in People of African Descent
• Two Powerful Imaging Tools Make Their Debut in the United States
